2011
DOI: 10.1002/ieam.111
|View full text |Cite
|
Sign up to set email alerts
|

How to test nontarget effects of veterinary pharmaceutical residues in livestock dung in the field

Abstract: To register veterinary medicinal products (VMPs) as parasiticides on pastured animals, legislation in the European Union requires an environmental risk assessment to test the potential nontarget effects of fecal residues on dung-dwelling organisms. Products with adverse effects in single-species laboratory tests require further, higher-tier testing to assess the extent of these effects on entire communities of dung-dwelling organisms under more realistic field or semifield conditions. Currently, there are no d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
44
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 25 publications
(44 citation statements)
references
References 52 publications
0
44
0
Order By: Relevance
“…However, with the exception of IVM and, to a lesser extent, MOX and DOR, the knowledge available from the open literature is still very limited. The immediate challenge therefore is to devise ways of filling the gaps in our knowledge base, focusing in particular on: The refinement and expansion of our understanding of pharmacokinetics and toxicology in order to provide a better basis for environmental risk assessment of MLs [325];Performance of tests on different levels (laboratory, semi-field and field) following standard test guidelines whenever possible (for coprophilous arthropods see, for example, OECD 2008 and OECD 2009) [52-53]; Performance of higher-tier studies under realistic (field) conditions, including structural (biodiversity) and functional (dung decomposition) endpoints (see for example Jochmann et al ) [326];Definition of the goals to be protected when assessing the potential environmental risks of new MLs and / or new formulations;Linking ecological knowledge ( e.g. population dynamics of single species) with ecotoxicological risk assessment, with a long-term aim of modelling the impact of these compounds on ecosystems in the field, particularly at the landscape level.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, with the exception of IVM and, to a lesser extent, MOX and DOR, the knowledge available from the open literature is still very limited. The immediate challenge therefore is to devise ways of filling the gaps in our knowledge base, focusing in particular on: The refinement and expansion of our understanding of pharmacokinetics and toxicology in order to provide a better basis for environmental risk assessment of MLs [325];Performance of tests on different levels (laboratory, semi-field and field) following standard test guidelines whenever possible (for coprophilous arthropods see, for example, OECD 2008 and OECD 2009) [52-53]; Performance of higher-tier studies under realistic (field) conditions, including structural (biodiversity) and functional (dung decomposition) endpoints (see for example Jochmann et al ) [326];Definition of the goals to be protected when assessing the potential environmental risks of new MLs and / or new formulations;Linking ecological knowledge ( e.g. population dynamics of single species) with ecotoxicological risk assessment, with a long-term aim of modelling the impact of these compounds on ecosystems in the field, particularly at the landscape level.…”
Section: Discussionmentioning
confidence: 99%
“…Performance of higher-tier studies under realistic (field) conditions, including structural (biodiversity) and functional (dung decomposition) endpoints (see for example Jochmann et al ) [326];…”
Section: Discussionmentioning
confidence: 99%
“…; Jochmann et al. ), thus extending the registration process already required for these drugs (VICH ). In this context, the issue of regionalization of substance control should also be considered, as is already being discussed (EFSA ).…”
Section: Discussionmentioning
confidence: 99%
“…Our results indicate a significant overall negative effect of endectocide fecal residues on the abundance of both larval and adult aphodiine beetles. The high heterogeneity (I 2 ) associated with study-specific factors (e.g., time of year, temperature, species, endectocide product, formulation) confirm the value of developing a standardized procedure for tier B testing (Jochmann et al 2011).…”
Section: Discussionmentioning
confidence: 89%
“…In addition, endectocides include both avermectins (e.g., doramectin, eprinomectin, ivermectin) and milbemycins (e.g., moxidectin) that can be formulated and administered to livestock as oral pastes, injections, extended‐release injections, pour‐ons, and sustained‐release boluses (Herd et al 1996). All of these factors influence fecal concentrations of endectocide residues entering the environment (Lumaret et al 2012) and the interpretation of results (Jochmann et al 2011). Relatively few studies have directly compared the nontarget effects of different endectocides (Hempel et al 2006; Webb et al 2010) or of the same endectocide in different formulations (Herd et al 1996).…”
Section: Introductionmentioning
confidence: 99%